AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
194.79
+2.89 (1.51%)
Sep 27, 2024, 4:00 PM EDT - Market closed
AbbVie Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for AbbVie stock have an average target of 195.25, with a low estimate of 150 and a high estimate of 218. The average target predicts an increase of 0.24% from the current stock price of 194.79.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 23, 2024.
Analyst Ratings
The average analyst rating for AbbVie stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
Buy | 7 | 8 | 8 | 8 | 8 | 8 |
Hold | 2 | 2 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $196 → $209 | Buy | Maintains | $196 → $209 | +7.30% | Aug 23, 2024 |
Morgan Stanley | Morgan Stanley | Buy Maintains $211 → $218 | Buy | Maintains | $211 → $218 | +11.92% | Aug 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +2.67% | Aug 5, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +2.67% | Jul 26, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $195 → $210 | Strong Buy | Reiterates | $195 → $210 | +7.81% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
56.80B
from 54.32B
Increased by 4.56%
Revenue Next Year
59.85B
from 56.80B
Increased by 5.38%
EPS This Year
11.10
from 2.72
Increased by 308.19%
EPS Next Year
12.33
from 11.10
Increased by 11.05%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 59.4B | 63.0B | 67.9B | ||
Avg | 56.8B | 59.9B | 64.2B | ||
Low | 54.1B | 55.9B | 59.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.3% | 10.9% | 13.4% | ||
Avg | 4.6% | 5.4% | 7.3% | ||
Low | -0.4% | -1.6% | -0.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.77 | 13.31 | 14.92 | ||
Avg | 11.10 | 12.33 | 13.80 | ||
Low | 10.50 | 11.25 | 12.57 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 332.7% | 19.9% | 21.0% | ||
Avg | 308.2% | 11.1% | 11.9% | ||
Low | 285.9% | 1.3% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.